I think a negative campaigning strategy is harmful - it just looks like we are bitter and negative and trying to settle scores against psychiatry and will make the reader wonder if the psychiatrists are right (as we are all so bitter and negative - perhaps we just need some therapy). I believe there will be a time of reckoning in the future when we have a clear understanding of the pathology of the disease(s).
Plus you need to consider the health literacy levels of the readership. On PR we sit and analyse every article that comes out in fine detail and have an in-depth understanding of the controversy and details of the PACE trial. The average reader isn't going to be interested in this stuff at all and may well be turned off when the article starts going over this ground.
If it were me and I had a short article, I'd present the following:
1) We are a large, underserved patient population with a high level of unmet medical needs.
2) Our disease has been neglected for decades - the cause was a mystery to doctors.
3) Now due to personal circumstances (Ron Davis) or serendipity (Norway) or growing awareness, some of the top researchers in the world are showing an interest in our disease and have some very exciting preliminary results.
4) These researchers have lots of great ideas and plans but they are being held back due to lack of funding. Therefore we need more funding so that these researchers can find a biomarker/treatment and cure and help this population of patients.
Plus you need to consider the health literacy levels of the readership. On PR we sit and analyse every article that comes out in fine detail and have an in-depth understanding of the controversy and details of the PACE trial. The average reader isn't going to be interested in this stuff at all and may well be turned off when the article starts going over this ground.
If it were me and I had a short article, I'd present the following:
1) We are a large, underserved patient population with a high level of unmet medical needs.
2) Our disease has been neglected for decades - the cause was a mystery to doctors.
3) Now due to personal circumstances (Ron Davis) or serendipity (Norway) or growing awareness, some of the top researchers in the world are showing an interest in our disease and have some very exciting preliminary results.
4) These researchers have lots of great ideas and plans but they are being held back due to lack of funding. Therefore we need more funding so that these researchers can find a biomarker/treatment and cure and help this population of patients.